JH
James Hill
Internal Medicine
Credentials: ·
History
- 2019–2023
Medical School
Research
Molecular Cancer Therapeutics · 2024 · 6 citations
Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
EMBO Reports · 2025 · 5 citations
Central nervous system relapse of core-binding factor acute myeloid leukemia
Leukemia & lymphoma/Leukemia and lymphoma · 2025 · First of 8 authors
2 papers · 2 as a resident
1 paper
- GB
1 paper
1 paper
1 paper
1 paper · 1 as a fellow
- KS
1 paper
1 paper
